Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.040
-0.060 (-5.45%)
Apr 29, 2026, 9:38 AM EDT - Market open
Alzamend Neuro Ratios and Metrics
Market cap in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 |
| Market Capitalization | 4 | 4 | 5 | 53 | 95 | - | |
| Market Cap Growth | -21.96% | -10.66% | -90.80% | -44.08% | - | - | |
| Enterprise Value | 1 | 1 | 5 | 46 | 83 | - | |
| Last Close Price | 1.10 | 5.94 | 63.99 | 738.85 | 1377.00 | - | |
| PB Ratio | 1.92 | 1.10 | -1.88 | 17.42 | 7.11 | - | |
| P/TBV Ratio | 1.92 | 1.10 | - | 17.42 | 7.11 | - | |
| Debt / Equity Ratio | - | - | -0.12 | - | - | 0.17 | |
| Net Debt / Equity Ratio | -1.24 | -0.99 | 0.03 | -1.69 | -1.05 | -0.79 | |
| Net Debt / EBITDA Ratio | 0.39 | 0.89 | 0.01 | 0.35 | 1.14 | - | |
| Net Debt / FCF Ratio | 0.44 | 0.57 | 0.01 | 0.58 | 2.09 | 0.59 | |
| Quick Ratio | 1.46 | 6.22 | 0.12 | 1.79 | 12.07 | 2.16 | |
| Current Ratio | 1.99 | 6.58 | 0.14 | 2.03 | 12.37 | 3.24 | |
| Return on Equity (ROE) | -249.97% | -657.17% | -4408.31% | -181.47% | -160.92% | -356.06% | |
| Return on Assets (ROA) | -107.01% | -107.38% | -189.73% | -90.97% | -88.35% | -130.96% | |
| Return on Capital Employed (ROCE) | -322.00% | -113.30% | 383.10% | -488.30% | -92.30% | -246.00% | |
| Earnings Yield | -180.27% | -103.51% | -203.75% | -28.04% | -13.03% | - | |
| FCF Yield | -147.41% | -157.47% | -172.40% | -16.82% | -7.08% | - | |
| Buyback Yield / Dilution | -765.27% | -499.67% | -4.07% | -9.45% | -22.64% | -1.96% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.